Cardio Agent (GW501516) – 20mg/tab – 50 tab EU Pharmaceutical

£46.00

Cardio Agent GW501516 20mg tablets from EU Pharmaceutical for research investigating PPARδ receptor pathways. Lab-grade compound for metabolic studies examining fatty acid oxidation mechanisms in cellular models.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Cardio Agent (GW501516) – 20mg/tab – 50 tab EU Pharmaceutical
Cardio Agent (GW501516) – 20mg/tab – 50 tab EU Pharmaceutical
£46.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Cardio Agent (GW501516) –: Compound Profile

Cardio Agent containing GW501516 is a PPARδ receptor agonist designed for laboratory investigation of metabolic pathways. This compound from Stroid UK Shop enables researchers to study peroxisome proliferator-activated receptor delta mechanisms in controlled experimental settings. Each tablet contains 20mg of pharmaceutical-grade material, suitable for investigating fatty acid oxidation, energy expenditure pathways, and metabolic regulation in cellular and tissue models.

Research Applications

Scientists examine GW501516’s role as a PPARδ agonist in metabolic research protocols. The compound demonstrates specificity for peroxisome proliferator-activated receptor delta, allowing researchers to investigate how this nuclear receptor family influences cellular energy metabolism. Laboratories studying endurobol compounds utilise this material to examine mitochondrial function, lipid metabolism pathways, and transcriptional regulation of genes involved in fatty acid β-oxidation. Researchers investigate its mechanisms in cell culture systems and tissue preparations to understand PPARδ-mediated cellular responses. Studies examine how PPARδ activation influences metabolic gene expression patterns and cellular energy homeostasis in various experimental models.

Product Specifications

Cardio Agent GW501516 Technical Data
Active Compound GW501516 (Cardarine)
Concentration 20mg per tablet
Quantity 50 tablets
CAS Number 317318-70-0
Molecular Formula C₂₁H₁₈F₃NO₃S₂
Molecular Weight 453.50 g/mol
Manufacturer EU Pharmaceutical
Storage Room temperature, protect from light

This formulation provides researchers with precise dosing capabilities for experimental protocols. The tablet format ensures consistent compound delivery in research applications. Scientists working with SARM research and related metabolic modulators find this material suitable for comparative studies. Each batch undergoes quality control testing to verify compound identity and purity. Research laboratories can integrate this material into studies examining PPARδ signalling pathways alongside investigations using peptide research compounds.

Research Compliance Statement

This product is intended strictly for in-vitro research and laboratory analytical purposes only. Not for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must follow appropriate safety protocols and institutional guidelines when handling this material. All studies should comply with relevant research ethics and safety regulations.

Related